Learn About a Research Study for Chronic Hives

For adults living with chronic hives, symptoms like burning, itching swelling, and pain can feel overwhelming. Everyday triggers – such as cold temperatures or even simple skin rubbing – often bring on flare-ups. Standard treatments, like daily antihistamines, may not provide enough relief.

The EMBARQ Study for cold urticaria (ColdU) and symptomatic dermographism (SD) is now enrolling volunteers. This research study is evaluating the safety and effectiveness of an investigational medication, given by injection, for people living with these conditions.

Individuals may qualify for the study if they:

• Are 18 years of age or older
• Have been diagnosed with ColdU or SD for at least 3 months prior to their first screening visit
• Continue to experience hives or itching despite daily use of an antihistamine
• Have been on a stable daily dose of an antihistamine for at least 4 weeks before joining the study
• Are willing to maintain a simple daily diary and comply with study procedures
• Are willing to have tests on skin that may temporarily cause hives or swelling
• Meet additional study criteria, which the study doctor will review during screening

If you are interested in learning more about this clinical research study, please fill out the form to see if you may be eligible.


Fill out the Form